SELLAS Life Sciences' Groundbreaking Cancer Therapy Receives Positive Recommendation and Key Data Presentations at Prestigious Conferences: $SLS SELLAS Life Sciences, a late-stage clinical… dlvr.it/T69WB4 #SLS #ClinicalStudy #MajorPharmaceuticalPreparations
The first patient in a new clinical study was treated at UTHealth Houston.
Read more: bit.ly/47Y3Orp
#cookmedical #clinicalstudy #firstpatient #treatment
Corcept Therapeutics Completes Enrollment in Trailblazing Trials: Harnessing the Potential of Cortisol Modulation in Battle Against Diabetes, ALS, and Ovarian Cancer: $CORT Corcept, widely… dlvr.it/T69MMZ #News #MajorPharmaceuticalPreparations #CORT #ClinicalStudy
New study out on alignment strategies in knee arthroplasty.
#knee #arthroplasty #alignment #outcome #clinicalstudy
Read here: doi.org/10.1002/ksa.12…
Biogen Making Strides in Innovative Therapies: Positive CHMP Opinions for TOFIDENCE and SKYCLARYS, and Resource Realignment for Alzheimer's Disease Franchise: $BIIB In exciting news for the pharmaceutical… dlvr.it/T62Szx #BiogenInc #ClinicalStudy #suppliers #BIIB #News
Exploring the Potential of Bezisterim (NE3107) in the Treatment of Long COVID, Parkinson's Disease, and Alzheimer's Disease: A Comprehensive Review: $BIVI In recent years, there has been a surge in research… dlvr.it/T69MLW #News #BIVI #customers #ClinicalStudy
Intrinseque Health...An EN ISO 13485 Certified, Full-service Global Clinical Supply Chain Company
#drugdiscovery #drugdevelopment #studystartup #clinicaltrial s #healthcare #clinicalresearch #patientrecruitment #sitemanagement #clinicaldevelopment #clinicaltrial #clinicalstudy
Groundbreaking Study Reveals Setmelanotide's Promising Results for Hypothalamic Obesity Treatment: $RYTM In a recent groundbreaking study published in The Lancet Diabetes and Endocrinology,… dlvr.it/T6BXHT #RhythmPharmaceuticalsinc #ClinicalStudy #News #customers #RYTM
Presenting our latest data from the UCSF CANDIDE study. #WomenInScience #clinicalStudy #WomenEmpowerment
Acrivon Therapeutics' ACR-368 Shows Promising Results in Ovarian and Endometrial Cancers: $ACRV Acrivon Therapeutics, a leading pharmaceutical company, presented initial positive… dlvr.it/T5ytz8 #ACRV #MajorPharmaceuticalPreparations #competitors #ClinicalStudy
SpringWorks Therapeutics Makes Waves at 2024 ASCO Meeting: Mirdametinib Phase 2b Trial Results Accepted for Presentation: $SWTX SpringWorks Therapeutics, a pioneering biopharmaceutical… dlvr.it/T5yXwd #customers #News #ClinicalStudy #SpringworksTherapeuticsInc #SWTX
FDA Fast-Tracks Approval for OJEMDA, Day One's Novel Treatment for Leading Childhood Brain Tumor, MARKS Major Leap Forward in Pediatric Oncology: $DAWN This latest regulatory green light… dlvr.it/T5wBCq #DayOneBiopharmaceuticalsInc #competitors #DAWN #ClinicalStudy
Aclarion's Nociscan Enhances Spine Health, Posts Record Revenue Increase As it Forges New Frontiers in Lower Back Pain Management: $ACON In a significant stride in the management of… dlvr.it/T60n16 #customers #AclarionInc #MedicalLaboratories #ACON #ClinicalStudy
Advances in CRISPR-Based Gene Editing Therapy for the Treatment of Hereditary Angioedema (HAE): $NTLA Hereditary angioedema (HAE) is a rare genetic condition characterized by recurrent… dlvr.it/T69JC2 #customers #ClinicalStudy #News #NTLA #IntelliaTherapeuticsInc
Regeneron Pharmaceuticals Unveils Promising Developments - EYLEA HD's Efficacy, Praluent's Expanded Application, and Linvoseltamab's FDA Priority Review: $REGN EYLEA, also known as aflibercept, has… dlvr.it/T69CRy #REGN #ClinicalStudy #News #RegeneronPharmaceuticalsInc
Cidara Therapeutics Dives into Promising Cloudbreak DFC Pipeline: Rezafungin Divestiture Marks Strategic Turnaround: $CDTX In a recent development, Cidara Therapeutics, a biotechnology company specializing in… dlvr.it/T5yv0J #ClinicalStudy #CidaraTherapeuticsInc
Less than 2 months after reaching 500 patients enrolled, we are delighted to have reached a new milestone in our e-ULTRA 10K registry with more than 1000 patients recruited so far at 40 active sites.
#pci #interventionalcardiology #clinicalstudy #biofreedomultra #stent #CERC
DARPin Therapeutic Innovation: Unwrapping Molecular Partners' Promising Leukemia Treatment Mechanism of Action: $MOLN Molecular Partners AG, a trailblazing biotechnical firm based in… dlvr.it/T69mzD #News #ClinicalStudy #suppliers #BiotechnologyandPharmaceuticals